April 2004
Gut;Apr2004 Supplement 3, Vol. 53, pA86
Academic Journal
Researchers have previously documented the value of contrast enhanced ultrasound in the assessment of the severely of liver disease. No direct comparison between serum markers such as hyaluronic acid and ultrasound has been reported. Serum HYA,, and HVTT are significantly different between cirrhotics and controls and hepatitis C patients. There is no correlation between HYA and IIIor HVTT, which reflects the overlap between HYA levels in the patient groups studied. In our study the ITI is a more reliable method for predicting cirrhosis.


Related Articles

  • Diagnostic Accuracy of Serum Hyaluronic Acid, FIBRO Spect II, and YKL-40 for Discriminating Fibrosis Stages in Chronic Hepatitis C. Mehta, Preeti; Ploutz-Snyder, Robert; Nandi, Jyotirmoy; Rawlins, Sekou R.; Sanderson, Schuyler O.; Levine, Robert A. // American Journal of Gastroenterology;Apr2008, Vol. 103 Issue 4, p928 

    OBJECTIVES: Noninvasive serum markers of liver fibrosis are being used as an alternative to liver biopsy. Currently available tests distinguish, with accuracy, only absent/minimal fibrosis (Ishak stages 0–1) and advanced fibrosis/cirrhosis (Ishak stages 4–6), but not intermediate...

  • Can serum hyaluronic acid replace simple non-invasive indexes to predict liver fibrosis in HIV/Hepatitis C coinfected patients? Resino, Salvador; Bellón, José M.; Asensio, Cristina; Micheloud, Dariela; Miralles, Pilar; Vargas, Ana; Catalán, Pilar; López, Juan C.; Álvarez, Emilio; Cosin, Jaime; Lorente, Raquel; Muñoz-Fernández, María A.; Berenguer, Juan // BMC Infectious Diseases;2010, Vol. 10 Issue 1, p244 

    Background: Hyaluronic acid (HA) serum levels correlate with the histological stages of liver fibrosis in hepatitis C virus (HCV) monoinfected patients, and HA alone has shown very good diagnostic accuracy as a non-invasive assessment of fibrosis and cirrhosis. The aim of this study was to...

  • Association of TIMP- 1 and TIMP- 2 Gene Polymorphisms with Progression of Liver Fibrosis in Patients with Type C Chronic Liver Disease. Ikebuchi, Yuichiro; Ishida, Chihiro; Okamoto, Kinya; Murawaki, Yoshikazu // Biochemical Genetics;Aug2013, Vol. 51 Issue 7/8, p564 

    We examined the association of TIMP- 1 and TIMP- 2 gene polymorphisms with the progression of chronic liver disease related to the hepatitis C virus (HCV). We used PCR to analyze 188 patients with HCV-related liver disease (95 with chronic hepatitis and 93 with cirrhosis) for TIMP- 1 372 T/C and...

  • FibroScan: A Noninvasive Test of Liver Fibrosis Assessment. Al-Ghamdi, Abdullah S. // Saudi Journal of Gastroenterology;Jul2007, Vol. 13 Issue 3, p147 

    Determination of the extent of progress of hepatic fibrosis is important in clinical practice, where it may reflect the severity of liver disease and predict response to treatment. Percutaneous liver biopsy is the gold standard for grading and staging of liver disease. However, liver biopsy is...

  • Diagnostic value of serum markers of connective tissue turnover for predicting histological staging and grading in patients with chronic hepatitis C. Murawaki, Yoshikazu; Ikuta, Yujiro; Okamoto, Kinya; Koda, Masahiko; Kawasaki, Hironaka // Journal of Gastroenterology;2001, Vol. 36 Issue 6, p399 

    Purpose. Chronic hepatitis C is an insidiously progressive disease, in which repeated assessment of liver histology is required. Various serum fibrotic markers have now been introduced. Our present aim was to assess, by receiver operating characteristic analysis, the usefulness of serum fibrotic...

  • Procollagen--III Peptide and Chronic Viral C Hepatitis. Jeffers, Lennox J.; Coelho-Littte, M. Ester; Cheinquer, Hugo; Vargas, Carlos; Civantos, Francisco; Alvarez, Luis; Reddy, K. Rajender; Parker, Talley; De Medina, Maria; Xiuming Li; Hill, Mary; LaRue, Silvia; Schiff, Eugene R. // American Journal of Gastroenterology;Sep1995, Vol. 90 Issue 9, p1437 

    Chronic hepatitis develops in at least half of persons acutely infected with hepatitis C virus (HCV), Ten to 25% of these patients will develop cirrhosis. Serum pro-collagen-III peptide (PIIIP) may be of value in predicting the development of chronic active fibrogenic liver disease. It has been...

  • HCV RNA Levels in Serum, Liver, and Peripheral Blood Mononuclear Cells of Chronic Hepatitis C Patients and Their Relationship to Liver Injury. Adinolfi, L. E.; Andreana, A.; Ulili, R.; Zampino, R.; Ragone, E.; Ruggiero, G. // American Journal of Gastroenterology;Nov1998, Vol. 93 Issue 11, p2162 

    Objective: We sought to evaluate the relationship between HCV RNA levels in serum, liver, and peripheral blood mononuclear cells (PBMC) and the degree of liver injury in chronic hepatitis C (CHC) patients. Methods: Thirty-six consecutive CHC patients were included in the study. The liver damage...

  • what the ND says.  // Better Nutrition;Jun2006, Vol. 68 Issue 6, p47 

    The article focuses on ways to protect oneself from hepatitis C. This slow-progressing disease is caused by a viral infection that causes liver inflammation and interferes with proper liver function. Hepatitis C can lead to fibrosis and eventually cirrhosis--which affects the blood flow in and...

  • Positive CAGE Screen Correlates with Cirrhosis in Veterans with Chronic Hepatitis C. Ahmad Kamal // Digestive Diseases & Sciences;Oct2007, Vol. 52 Issue 10, p2564 

    Abstract  The current study examines the relationship between problem alcohol use and severity of liver disease by self-administered questionnaires using both the CAGE questionnaire and beverage-specific quantity-frequency questions. The cohort consisted of 38 patients with...


Read the Article


Sign out of this library

Other Topics